Skip to main content
Premium Trial:

Request an Annual Quote

Vibrent Health Lands $39M in NIH Funding to Continue All of Us Tech Center

NEW YORK – Vibrent Health said on Wednesday that it has received a $39 million award from the US National Institutes of Health to continue serving as the Participant Technology Systems Center (PTSC) for the All of Us research program. The new funding covers the first year of what is expected to be a five-year effort, according to the company.

NIH directs potential participants to Vibrent's web and mobile platform to enroll, share their health information, and register for program updates. Fairfax, Virginia-based Vibrent Health runs all consumer-facing technology for All of Us, and the PTSC platform supports more than 100 program partners.

"As an All of Us technology partner, the PTSC provides the infrastructure to help people enroll, contribute information securely, and stay connected with the program over time," All of Us CEO Joshua Denny said in a statement. "This provides the foundation for critical discoveries that may help improve health in the future."

More than 356,000 people have consented to participate in All of Us — and have enrolled on Vibrent Health's platform — and 270,000 people have completed the full protocol, which involves donating biological samples and sharing a variety of data from electronic medical records, surveys, and wearables.

"Our successes, combined with our second PTSC award from the NIH, have led us to fulfill our vision of a more personalized, inclusive, and transformative platform that can unlock the full potential of health data in ways that stand to change the course of human health," said Vibrent Health Founder and CEO Praduman Jain.

 

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.